Paper309487
Enhancement of T cell cytotoxic responses by purified human fibroblast interferon.
Zarling JM and 5 others. J Immunol, 1978. Cited by 88 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Enhancement of T cell cytotoxic responses by purified human fibroblast interferon. Papers, record 309487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/309487
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytotoxicity, Immunologic | Major topic |
| Interferons | Major topic |
| T-Lymphocytes | Major topic |
| Fibroblasts | |
| Humans | |
| Isoantigens |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30679806 | Interferons α and β in cancer: therapeutic opportunities from new insights. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30679806 | PubMed |
| 8984676 | Mechanisms of action of interferon-beta in multiple sclerosis. | Springer Semin Immunopathol | 1996 | https://conductscience.org/library/papers/8984676 | PubMed |
| 6676984 | Biosynthetic human interferon treatment of herpetic keratitis. | Trans Am Ophthalmol Soc | 1983 | https://conductscience.org/library/papers/6676984 | PubMed |
| 6403469 | Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon. | Infect Immun | 1983 | https://conductscience.org/library/papers/6403469 | PubMed |
| 6308051 | Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6308051 | PubMed |
| 6176663 | Interferon inhibits the generation of allospecific suppressor T lymphocytes. | J Exp Med | 1982 | https://conductscience.org/library/papers/6176663 | PubMed |
| 6174540 | Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon. | J Clin Immunol | 1981 | https://conductscience.org/library/papers/6174540 | PubMed |
| 6167513 | Antiviral agents: an update--Part 2. | Indian J Pediatr | 1980 | https://conductscience.org/library/papers/6167513 | PubMed |
| 6165341 | Differences between human alpha (leukocyte) and beta (fibroblast) interferons. | Arch Virol | 1981 | https://conductscience.org/library/papers/6165341 | PubMed |
| 6155926 | Enhancement of human natural cell-mediated cytotoxicity by interferon. | Br J Cancer | 1980 | https://conductscience.org/library/papers/6155926 | PubMed |
| 3416325 | Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy. | Cancer Immunol Immunother | 1988 | https://conductscience.org/library/papers/3416325 | PubMed |
| 3127093 | Role of IL-2 and interferon in the generation of natural cytotoxic activity in influenza virus-stimulated PBL cultures: analysis with the use of prednisolone. | Clin Exp Immunol | 1988 | https://conductscience.org/library/papers/3127093 | PubMed |
| 2484953 | Effects of interferons on human B-cell differentiation in vitro. | Korean J Intern Med | 1987 | https://conductscience.org/library/papers/2484953 | PubMed |
| 2440628 | Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts. | Clin Exp Immunol | 1987 | https://conductscience.org/library/papers/2440628 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IFNB1 | 3456 | PubTator's text mining | https://conductscience.org/library/genes/3456 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/309487
GET https://conductscience.org/api/papers/v1/309487/authors